Salmeterol/fluticasone propionate combination therapy 50/250 μ g twice daily is more effective than budesonide 800 μ g twice daily in treating moderate to severe asthma

Three hundred and fifty-three asthmatic patients who remained symptomatic despite treatment with budesonide 800–1200 μ g day−1(or equivalent) were randomized to a new combination therapy comprising salmeterol 50 μ g and fluticasone propionate 250 μ g (SeretideTM, AdvairTM, VianiTM50/250 μ g) twice d...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Respiratory medicine 2000-07, Vol.94 (7), p.715-723
Hauptverfasser:	JENKINS, C., WOOLCOCK, A.J., SAARELAINEN, P., LUNDBÄCK, B., JAMES, M.H.
Format:	Artikel
Sprache:	eng
Schlagworte:	asthma Biological and medical sciences budesonide DiskusTM fluticasone propionate Medical sciences Pharmacology. Drug treatments Respiratory system salmeterol
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!